Psychedelic Drugs and Creativity

Krippner opens by situating the use of psychoactive plants and compounds as long-standing tools for altering consciousness and, by extension, as resources invoked in creative practice. The paper summarises historical and anecdotal reports linking psychedelic substances (for example, mescaline, psilocybin and LSD) to artistic insight, problem solving and changes in aesthetic sensibility, while noting that systematic scientific work has produced mixed and sometimes contradictory findings. This article sets out to review empirical and case-based literature on psychedelics and creativity and to present the author's own interview and survey data from artists and musicians. Krippner aims to clarify what prior studies have observed about acute and longer-term effects of psychedelics on creative processes, to report patterns from a large convenience sample of practising artists and to highlight methodological issues and directions for future research.

The paper combines a narrative review of prior experimental and case-study literature with original empirical work carried out by the author. The literature review summarises a series of mostly small studies and clinical reports that administered LSD, psilocybin, mescaline and related compounds to artists, creative professionals, students and volunteers; design features of those studies varied and included open-label and controlled designs, pilot projects and case histories. Krippner's primary empirical contribution was a survey of 180 professionally committed artists (151 men, 29 women), drawn largely from the New York area but including respondents from other countries. The sample was not random or systematic: some interviews were conducted in person and others by mailed questionnaire. The author used a working definition of a "psychedelic artist" (based on prior work) and asked respondents about lifetime psychedelic experiences, substances used, subjective valence of trips, and perceived influences of such experiences on artistic content, technique and approach. In addition, Krippner interviewed 27 pop musicians in 1968–69, asking about drug use and effects on performance and creativity. When summarising prior experimental work, the paper reports study designs and measures where available: examples include McGlothlin's controlled multi-session LSD study with 72 graduate students (three groups of 24), Zegans et al.'s randomized administration of LSD to 19 subjects versus 11 controls with a battery including remote association and visual attention tests, Harman et al.'s mescaline sessions with professional problem solvers using creativity tests (e.g., Purdue Creativity Test, visualization and embedded figures tests), and various small studies of artists painting during drug sessions. The paper notes methodological limitations in many cited studies, including small samples, pilot status, variability in dosages and the non-random quality of some subject pools.

Across the reviewed experimental literature, results were heterogeneous. Several small studies reported that while psychedelics often increased imaginative or unusual associations, they frequently impaired motor control, concentration or technical execution. For example, studies in which artists painted while intoxicated found bolder lines and more vivid colour use but reduced technical precision. Pittel and others reported heightened primary process thinking but reduced capacity to translate imagery into controlled, objective description. Controlled work produced mixed findings. McGlothlin's study (72 graduate students; three-session LSD series at 200 µg) found that 62% of experimental subjects reported greater appreciation of music six months later and that the experimental group increased museum attendance and record purchases, but standardised art tests did not show systematic improvements in creative performance; one art measure (Draw-A-Person) decreased for LSD subjects at six months. Zegans, Pollard and Brown (30 male graduate students) found that LSD subjects performed significantly better on a test of originality in word association (a measure of remote associations) but worse on tasks requiring narrowed visual attention; the authors interpreted this as increased access to remote ideas while visual attentional narrowing suffered. Harman and colleagues' mescaline study with professional problem solvers reported more consistently positive, task-relevant results. On the Purdue Creativity Test subjects showed a statistically significant increase in fluency of ideas (averaging about a 30 percentile point rise), visualization tasks improved significantly, and almost all subjects improved on the Embedded Figures Test (some up to 200%), indicative of a shift toward field independence (a cognitive style often linked with creative problem solving). Subjective reports in that study were mixed: roughly half reported accomplishing much more during the session, about 20% were distracted by non-task imagery, and the remainder had intermediate responses. Krippner's survey of 180 artists produced descriptive findings about patterns of use and perceived effects. Of the 180, 155 agreed with the offered definition of a "psychedelic artist" and 144 described themselves as such; 162 reported having ingested psychedelic substances, while 18 had not. Marijuana was the most commonly reported substance (mentioned by all but one respondent), followed by illicitly manufactured LSD, hashish, DMT, mescaline, peyote and psilocybin among others. When asked about valence, 149 artists said their psychedelic experiences were generally pleasant; 26 gave a qualified affirmative and a handful reported negative or mixed responses. In relation to artistic influence, respondents cited three broad domains of change: content (114 artists reported changes, often involving eidetic or visionary imagery), technique (131 reported improvements, frequently mentioning greater facility with colour) and creative approach (142 reported shifts, such as deeper thematic concerns or a move away from superficiality). Krippner notes that these are self-reports from a non-representative sample and should be interpreted cautiously. Among 27 interviewed pop musicians, all had smoked marijuana and 24 had tried LSD. Views on performance effects varied: five preferred marijuana before performing, seven found it impairing, three reported that LSD enhanced performance, six reported no effect and 15 believed LSD or similar drugs harmed their performance. The paper documents numerous anecdotal long-term influences on artists' work and provides illustrative quotations (for example, one painter said a guided LSD session "opened thousands of doors for me and dramatically changed the content, intent, and style of my work"). The review also summarises proposed mechanisms: several authors suggest psychedelics alter information-processing subsystems (following Tart's framework) such as input processing, memory and sense of self; visual phenomenology (heightened colours, altered figure–ground) has been linked to retinal and neural factors and to altered central processing, offering raw material that artists may later rework. Krippner emphasises the role of expectancy, personality and setting in shaping outcomes.

Krippner interprets the body of evidence as indicating that psychedelic drugs do not uniformly enhance creativity; rather, effects depend on the task, the individual and the context. Acute intoxication often impairs motor precision and focused attention, so activities requiring technical execution (for example, live musical performance or fine draughtsmanship) are frequently harmed. Conversely, many studies and numerous artists' self-reports point to increased access to unusual imagery, remote associations and altered aesthetic sensibilities, which can serve as raw material for later creative work or lead to enduring changes in artistic approach. The author situates these findings relative to earlier conceptions that psychedelics produce a simple "model psychosis," arguing instead for a more nuanced view in which chemical effects interact with personality, expectation and set/setting to evoke particular experiences. Krippner highlights especially the divergent outcomes between studies using unselected volunteers (which generally show no reliable enhancement of standardised creativity tests) and studies involving experienced, creative professionals or problem-focused sessions (which tend to produce more positive, task-relevant changes). Key limitations are acknowledged: many cited studies were small, exploratory or lacked rigorous controls; samples were often convenience-based and non-representative; reports from artists and musicians rely heavily on retrospective self-report and are subject to expectancy and recall biases; illicitly produced preparations complicate interpretation because dose and purity were frequently unknown. The author also notes that some creativity measures used in older studies may not capture the kinds of change artists report, and that subjective increases in aesthetic appreciation do not necessarily map onto improved performance on standardised tests. In terms of implications, Krippner argues for renewed scientific attention to psychedelics and creativity, given advances in information theory, neuroscience and consciousness studies. The paper recommends more systematic research that combines rigorous experimental controls with ecological validity for creative practice, better measurement of creative outcomes, attention to set and setting, and exploration of individual differences that moderate responses. Krippner frames such work as an opportunity to deepen scientific understanding of the creative act rather than as an endorsement of recreational use.